Cloud Banner

Medical Devices

Image

Global Diabetic Lancing Device Market – Industry Trends and Forecast to 2028

  • Medical Devices
  • Upcoming Report
  • Mar 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Diabetic Lancing Device Market, By Type (Safety Lancets, Standard Lancets), Gauge (17/18g, 21g, 23g, 25g, 28g, 30g, Others), Penetration Depth (8 mm to 1.0 mm, 1 mm to 1.5 mm, 6 mm to 2.0 mm, 1 mm to 2.5 mm, 5 mm to 3.0 mm), Application (Hospitals & Clinics, Home Care & Home Diagnostics, Diagnostic Centers & Medical Institutions, Research & Academic Laboratories, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.

Diabetic Lancing Device Market Market Analysis and Insights : Global Diabetic Lancing Device Market

Diabetic lancing device market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to reach at an estimated value of USD 1,742.01 million and grow at a CAGR of 10.28% in the above-mentioned forecast period. Increasing prevalence of diabetes among the population in developed and developing countries drives the diabetic lancing device market.

Diabetes is defined as a disease which occurs due to high blood glucose levels. Lancing device is also known as a blood sampling device, which is mostly used by diabetics during blood glucose monitoring, and the device is equipped with a lancet. Lancing devices are basically reusable, but the lancet can be used for a single check and also operating the lancing device is simple and the device is very easy to use, which results in the increasing preference for personal use.

Increasing awareness regarding use of blood glucose monitoring devices and safety measure devices to avoid infectious diseases is the vital factor escalating the market growth, also rise in prevalence of diabetic population, increased awareness about safety measures in order to avoid infectious diseases, rise in the awareness about blood glucose monitoring devices, increasing healthcare expenditure, easy access for the treatment due to increasing number of hospitals, rising number of diabetic patients due to unhealthy lifestyle of the people and rising cases of diabetes in young generation due to bad genetics and improper diet during the forecast period are the major factors among others driving the diabetic lancing device market. Moreover, rising technological advancements and modernization in the healthcare devices, rising research and development activities in the healthcare sector and rising emerging markets with increasing geriatric population will further create new opportunities for diabetic lancing device market in the forecasted period of 2021-2028.

However, increasing traditional Chinese medicine as an alternative and increasing cost of advanced diabetes management devices are the major factors among others which will obstruct the market growth, while rising lack of adherence of patients to recommended diabetes treatment guidelines will further challenge the growth of diabetic lancing device market in the forecast period mentioned above.

Diabetic lancing device market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on diabetic lancing device market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Diabetic Lancing Device Market Scope and Market Size

Diabetic lancing device market is segmented on the basis of type, gauge, penetration depth and application. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of type, diabetic lancing device market is segmented into safety lancets and standard lancets.
  • Based on gauge, the diabetic lancing device market is segmented into17/18g, 21g, 23g, 25g, 28g, 30g and others.
  • Based on penetration depth, the diabetic lancing device market is segmented into 8 mm to 1.0 mm, 1 mm to 1.5 mm, 6 mm to 2.0 mm, 1 mm to 2.5 mm and 5 mm to 3.0 mm.
  • The diabetic lancing device market is also segmented on the basis of application into hospitals & clinics, home care & home diagnostics, diagnostic centers & medical institutions, research & academic laboratories and others.

Diabetic Lancing Device Market Country Level Analysis

Diabetic lancing device market is analysed and market size insights and trends are provided by country, type, gauge, penetration depth and application as referenced above.

The countries covered in the diabetic lancing device market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the diabetic lancing device market due to rising prevalence of diabetes coupled with growing preference for diabetes lancing devices in this region. Europe is the expected region in terms of growth in diabetic lancing device market due to rising change in individual lifestyle and rising research and development activities for improvement of new medication and devices in this region. Asia-Pacific is also expected to grow in diabetic lancing device market due to rising presence of a large number of lancet manufacturers from emerging economies such as India, Japan, South Korea, and China in this region.

The country section of the diabetic lancing device market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Diabetic lancing device market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for diabetic lancing device market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the diabetic lancing device market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Diabetic Lancing Device Market Share Analysis

Diabetic lancing device market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to diabetic lancing device market.

The major players covered in the diabetic lancing device market report are BD, F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc., Sanofi, Novo Nordisk A/S, Ypsomed Holding, Ascensia Diabetes Care Holdings AG, Dexcom, Inc., ARKRAY USA, Inc., Bayer AG, Amylin Pharmaceuticals Inc., Abbott, Medtronic Inc., Teva Pharmaceuticals Pvt Ltd., Home Diagnostics Inc., Novartis AG, Eli Lilly and Company, Merck & Co., Inc, AstraZeneca, Boehringer Ingelheim International GmbH. and Terumo Corporation among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Diabetic lancing device market is to reach an estimated value of USD 1,742.01 million and is growing at a CAGR of 10.28% in the forecasted period by 2028.
Diabetic lancing device market is segmented on the basis of type, gauge, penetration depth and application.
The countries covered in the diabetic lancing device market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
The major players covered in the diabetic lancing device market report are BD, F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc., Sanofi, Novo Nordisk A/S, Ypsomed Holding, Ascensia Diabetes Care Holdings AG, Dexcom, Inc., ARKRAY USA, Inc., Bayer AG, Amylin Pharmaceuticals Inc., Abbott, Medtronic Inc., Teva Pharmaceuticals Pvt Ltd., Home Diagnostics Inc., Novartis AG, Eli Lilly and Company, Merck & Co., Inc, AstraZeneca, Boehringer Ingelheim International GmbH. and Terumo Corporation
North America dominates the diabetic lancing device market due to rising prevalence of diabetes coupled with growing preference for diabetes lancing devices in this region.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials